Hamilton Rating Scale for Depression (HRSD, HAM-D)

The original PDF for the Hamilton Rating Scale for Depression can be downloaded here.

​

Abstract

The Hamilton Rating Scale for Depression (HRSD), also known as the HAM-D, was developed by Max Hamilton in 1960 as a standardized clinical instrument for assessing the severity of symptoms in patients diagnosed with depressive disorders. This instrument is administered through a structured interview and is designed to quantify the results of that clinical interaction, providing a measurable score of depressive symptomatology.

The HRSD traditionally consists of 17 variables, although variations exist. The items are scored using different scales: some utilize a five-point scale, while others are rated on a three-point scale. Beyond core mood and somatic symptoms, the scale incorporates specific variables relevant to complex psychiatric presentations, including phenomena such as Diurnal variation, derealization, paranoid symptoms, and obsessional symptoms.

Keywords

Hamilton Rating Scale for Depression, HRSD, HAM-D, Major Depression, Rating Scale, Test Construction, Test Development, Clinical Assessment, Psychometrics

Authors

Hamilton, Max

​

Purpose

The primary purpose of the Hamilton Rating Scale for Depression (HRSD) is to provide a standardized, objective measure for the assessment of symptoms in patients who have been diagnosed with depressive disorders. It is widely used in clinical trials and research settings to track changes in symptom severity over time, particularly in response to pharmacological or psychological interventions.

The scale serves to quantify subjective and objective clinical observations gathered during an interview. By converting qualitative interview results into quantifiable scores, the HRSD allows clinicians and researchers to establish baseline severity, monitor treatment efficacy, and define criteria for remission or relapse in a reliable manner.

Construct

The HRSD is designed to measure the psychological construct of Depression. It focuses specifically on the cluster of affective, cognitive, somatic, and behavioral symptoms that characterize major depressive episodes as defined in clinical nosology.

The 17 items comprising the scale cover a broad spectrum of depressive features, ranging from core symptoms like depressed mood, guilt, and suicidal ideation, to vegetative symptoms such as sleep disturbance, weight loss, and psychomotor changes. The inclusion of items related to anxiety, hypochondriasis, and specific psychotic features (e.g., paranoid symptoms) reflects an attempt to capture the heterogeneity often associated with clinical depression.

Validity

Initial investigations into the validity of the HRSD focused on its ability to predict treatment outcomes, a form of Predictive validity. In an early study involving 64 patients, 49 of whom were followed up after receiving treatment, the relationship between baseline HRSD scores and subsequent outcome was examined.

Analysis revealed that only Factor 3 of the scale structure showed a statistically significant correlation with treatment outcome, yielding a coefficient of 0.27. However, the relatively low magnitude of this correlation raises questions regarding the practical or clinical relevance of this specific factor in predicting recovery. Other established factors within the scale structure demonstrated weaker correlations with the observed outcomes, suggesting variance in the predictive power across different symptom clusters measured by the HRSD.

Reliability

The reliability of the HRSD is frequently assessed via Interrater reliability, a crucial metric given the instrument’s reliance on clinical judgment during the interview process. High interrater reliability ensures that different clinicians rating the same patient arrive at similar scores, thereby confirming the scale’s consistency and objectivity.

In the initial development study, the correlation between summed scores assigned by two independent raters was calculated. For the first 10 patients assessed, the correlation coefficient was 0.84, indicating strong agreement. As the raters gained experience and assessed a larger sample, the reliability improved further, reaching a correlation coefficient of 0.90 for the final 70 patients. This high level of consistency confirms the scale’s utility as a reliable measure when administered by trained personnel.

Factor Analysis

While the HRSD is commonly used as a unidimensional measure of overall depression severity, factor analysis research has consistently indicated that the scale is multidimensional. The original source content specifically references the existence and importance of “Factor 3” when discussing predictive validity, suggesting an underlying factor structure was considered during the scale’s development and validation.

Factor analytic studies typically identify several distinct factors within the HRSD, often including factors related to Anxiety/Somatic symptoms, Cognitive disturbance, and Retardation/Sleep disturbance. The identification of Factor 3’s significant, though modest, correlation with treatment outcome (0.27) suggests that this specific component of depressive symptomatology holds unique predictive value, even if its clinical implications remain complex and subject to further interpretation.

Instrument

Test Type: Rating Scale (Clinician-rated, Interview-based)

Format: The HRSD consists of 17 core variables, with scoring based on either a three-point (0-2) or five-point (0-4) severity scale, depending on the item.

Language Available: Original publication in English; numerous translations are available globally.

Population Group: Human, Male (Initial validation sample details)

Age Group: Adulthood (18+ years), Thirties (30-39), Middle Age (40-64), Aged (65+)

Population Details: Psychiatric patients diagnosed with depressive disorders.

Test Methodology: The scale utilizes standard psychometric methods, including Test Validity, Predictive Validity, Test Reliability, and Interrater Reliability assessment.

Keywords

Major Depression, Clinical Assessment, Psychiatric Assessment, Diurnal variation, Paranoid symptoms, Obsessional symptoms, Derealization, Test Reliability

​

Authors

Author ORCID Identifier: Not provided in source content.

Affiliation Email addresses: Not provided in source content.

Correspondence Address: Not provided in source content.

Permissions & Fee and Test Year

The original HRSD was published in 1960. As this is a widely utilized clinical and research instrument, researchers should verify current usage permissions and potential licensing fees, particularly for commercial applications, by contacting the journal publisher or relevant academic copyright holders.

Classification: 6700 Mental Health/Illness Related Assessment

Reference’s

• Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery & Psychiatry, 23, 56–61. https://doi.org/10.1136/jnnp.23.1.56

• Digital Object Identifier (DOI) for the scale entry: https://doi.org/10.1037/t04100-000

​

Items of the Hamilton Rating Scale for Depression (HRSD, HAM-D)

IMPORTANT: The following scale items must be preserved in their original language and must not be changed in any way.

The source content does not provide the full list of the 17 core items of the HRSD. However, the description highlights specific variables included in the assessment:

• Diurnal variation

• Derealization

• Paranoid symptoms

• Obsessional symptoms